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Abstract
Venereal syphilis is a multi-stage, sexually transmitted disease caused by the spirochetal bacterium Treponema pallidum (Tp).
Herein we describe a cohort of 57 patients (age 18–68 years) with secondary syphilis (SS) identified through a network of
public sector primary health care providers in Cali, Colombia. To be eligible for participation, study subjects were required to
have cutaneous lesions consistent with SS, a reactive Rapid Plasma Reagin test (RPR-titer $1:4), and a confirmatory
treponemal test (Fluorescent Treponemal Antibody Absorption test- FTA-ABS). Most subjects enrolled were women (64.9%),
predominantly Afro-Colombian (38.6%) or mestizo (56.1%), and all were of low socio-economic status. Three (5.3%) subjects
were newly diagnosed with HIV infection at study entry. The duration of signs and symptoms in most patients (53.6%) was
less than 30 days; however, some patients reported being symptomatic for several months (range 5–240 days). The typical
palmar and plantar exanthem of SS was the most common dermal manifestation (63%), followed by diffuse hypo- or
hyperpigmented macules and papules on the trunk, abdomen and extremities. Three patients had patchy alopecia. Whole
blood (WB) samples and punch biopsy material from a subset of SS patients were assayed for the presence of Tp DNA
polymerase I gene (polA) target by real-time qualitative and quantitative PCR methods. Twelve (46%) of the 26 WB samples
studied had quantifiable Tp DNA (ranging between 194.9 and 1954.2 Tp polA copies/ml blood) and seven (64%) were
positive when WB DNA was extracted within 24 hours of collection. Tp DNA was also present in 8/12 (66%) skin biopsies
available for testing. Strain typing analysis was attempted in all skin and WB samples with detectable Tp DNA. Using arp
repeat size analysis and tpr RFLP patterns four different strain types were identified (14d, 16d, 13d and 22a). None of the WB
samples had sufficient DNA for typing. The clinical and microbiologic observations presented herein, together with recent
Cali syphilis seroprevalence data, provide additional evidence that venereal syphilis is highly endemic in this region of
Colombia, thus underscoring the need for health care providers in the region to be acutely aware of the clinical
manifestations of SS. This study also provides, for the first time, quantitative evidence that a significant proportion of
untreated SS patients have substantial numbers of circulating spirochetes. How Tp is able to persist in the blood and skin of
SS patients, despite the known presence of circulating treponemal opsonizing antibodies and the robust pro-inflammatory
cellular immune responses characteristic of this stage of the disease, is not fully understood and requires further study.
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Introduction
Syphilis is a sexually transmitted disease (STD) caused by the
spirochetal bacterium Treponema pallidum (Tp) subspecies pallidum
[1,2]. Despite the existence of inexpensive and effective antibiotic
treatment regimens, syphilis continues to be a major public health
problem. According to the most recent World Health Organiza-
tion (WHO) estimates, approximately 10.6 million new syphilis
cases occur yearly throughout the globe [3]. Although venereal
syphilis has re-emerged in developed countries [4], most
individuals (.90%) who acquire the disease reside in less affluent
regions of the world [3]. In Cali, Colombia, our Latin American
study site, the yearly incidence of venereal syphilis over the last
decade was estimated to be around 32 cases per 100,000 (GE
Aristizabal, City of Cali Health Department’s STD Division -
personal communication). This approximation is significantly
higher than in Western Europe [5] or in the United States [4],
and based on the very high rates of well documented gestational
and congenital syphilis rates in the city [6], it very likely
underestimates the true prevalence of venereal syphilis in Cali.
www.plosntds.org 1 May 2010 | Volume 4 | Issue 5 | e690Indeed, in a recent study conducted by our collaborators [7], 1.2–
6.8% of 23,190 sexually active 15–24 year old men and women,
from different socioeconomically deprived Cali districts ‘‘comu-
nas’’, had serum RPR values $1:8. In the same study, 13.8% of
men who have sex with men (MSM), 28.8% of female commercial
sex workers and 39.2% of transsexuals in Cali were also found to
be sero-positive for syphilis [7]. Strategies to control sexual
transmission of Tp are, thus, urgently needed in Colombia, not
only because of the harmful consequences of syphilis to infected
pregnant women or their unborn children [5,8,9], but also because
of the strong association of venereal syphilis with an increased risk
for acquiring and transmitting human immunodeficiency virus
(HIV) [4,10–12]. To begin to curb the spread of venereal syphilis it
is very important that health care providers become more adept at
distinguishing the typical and atypical signs and symptoms
associated with early syphilitic infection.
Unlike most invasive bacterial infectious diseases, venereal
syphilis is a multistage illness with clinical manifestations that
reflect the propensity of Tp to disseminate systemically and to
induce persistent chronic inflammation in diverse tissues and
organ systems [1,2,13,14]. Infection begins when the bacterium
comes in contact with skin or mucosal membranes, multiplying
locally over several days, while simultaneously disseminating
through blood vessels and lymphatics [2,15]. The appearance of
a painless ulcer, more commonly known as a ‘‘chancre’’, typically
only appears 2–4 weeks after the initial contact with the spirochete
[2,15,16]. By this time, organisms have disseminated from the
primary site of infection to various organ systems and throughout
the dermis [2,15], setting the stage for what is classically known as
secondary syphilis. This stage of the disease, which is the principal
focus of the current study, is characterized by the most overt
systemic clinical features, including a variety of dermal manifes-
tations as well as systemic signs and symptoms typically appearing
within 4–10 weeks of the initial infection [13,14]. Despite the
evolving nature of the adaptive immune response [17], including
the presence of opsonic antibodies [18], it may take weeks and in
some cases months for the host to gain the upper hand against the
invading pathogen, ultimately giving rise to an asymptomatic stage
known as latent syphilis. During early latency (the first 4 years
post-infection) patients may experience recurrences of spirochet-
emia as well as clinical relapses [13,15,19], both indicative of the
host’s inability to fully eradicate and control the bacterium. In due
course, patients enter late latency and several years later 15–40%
of them develops recrudescent forms of the disease; collectively
referred to as tertiary syphilis [14,20,21]. How the bacterium
disseminates from its primary or secondary sites of infection, and
why it persists in its human host for extended periods of time
despite the vigorous cellular and humoral adaptive immune
responses it evokes [2,17], remains unresolved.
Greater progress towards deciphering the pathogenesis of the
paradoxical nature of venereal syphilis has been hampered due to
the inability to readily propagate Tp in vitro, as well as the lack of a
suitable inbred animal model to study the disease. Nevertheless,
much can be learned about the pathogenesis of venereal syphilis
through a combined analysis of the epidemiologic, clinical and
microbiologic features of the various stages of the disease. In the
current study we review the clinical, histopathologic and
laboratory features of 57 patients diagnosed with SS through a
network of public sector primary health care providers in Cali,
Colombia. Concurrently we determined spirochetal DNA burdens
in WB and skin samples from a subset of these patients by using a
highly sensitive real-time PCR assay. In conjunction with available
Cali syphilis seroprevalence data [7], this study provides clinical
and microbiologic evidence that venereal syphilis is highly
endemic in this region of Colombia. Our findings also make
evident that in this population early syphilis patients may go
undiagnosed and untreated for several weeks, in some cases for
several months. We also provide, for the first time, quantitative
and/or qualitative molecular evidence that spirochetes are present
in significant numbers in skin and blood of untreated SS patients.
Paradoxically, spirochetes persisted despite the known presence of
circulating antitreponemal opsonizing antibodies in the serum of
SS patients [18], as well as the robust pro-inflammatory dermal
cellular immune response characteristic of this stage of the disease
[17].
Materials and Methods
Subject Recruitment
SS patients from Cali, Colombia were recruited from 2003 to
2009 as part of an ongoing syphilis immunology study [10]. Cali is
the 3
rd largest city in Colombia with a population of 2,139,535;
many of whom belong to middle or low socio-economic strata
(32.1% and 31.6% respectively). Out of 22 distinct comunas in the
city, 11 are considered very poor, have less than adequate access to
health care services and as already alluded to above, very high
RPR seropositivity rates [7]. Five public health institutions called
Empresas Sociales del Estado (ESEs) are strategically located
throughout the city, and are responsible for providing regional
health care to the local population residing in the various comunas
(Figure 1). Prior to study initiation, nurses and physicians working
in decentralized hospitals and health care centers affiliated to
individual ESEs were trained by study personnel to properly
recognize and treat early syphilis patients. Patients who met
criteria for a diagnosis of SS and who agreed to participate in the
study were referred by participating providers to the ‘‘Centro
Internacional de Entrenamiento e Investigaciones Me ´dicas’’
(CIDEIM) for further examination by study physicians and for
confirmatory blood tests. At CIDEIM all participants were
required to sign informed consent. Study procedures were
reviewed and approved by the human subjects boards at the
Connecticut Children’s Medical Center, the University of
Connecticut Health Center (UCHC), Walter Reed Army Institute
Author Summary
Venereal syphilis is a sexually transmitted disease caused
by the bacterium Treponema pallidum (Tp). We describe 57
patients (age 18–68 years) from Cali, Colombia diagnosed
with secondary syphilis (SS). Most were women (64.9%);
predominantly Afro-Colombian (38.6%) or mestizo (56.1%),
and all of low socio-economic status. Three (5.3%) were
newly diagnosed with HIV infection at study entry. The
typical palmar and plantar rash of SS was the common
clinical finding (63%). Whole blood (WB) samples and skin
biopsies were assayed for Tp DNA by using molecular
methods. 46% of the WB samples had circulating Tp DNA
and 64% were positive when the DNA was extracted on
the same day of collection. Tp DNA was also present in the
skin of 66% (12/26) of biopsies tested by PCR. We conclude
that primary care providers in countries like Colombia
need to remain highly vigilant for the clinical presentation
of SS. The study also provides, for the first time, qualitative
and quantitative evidence that untreated SS patients have
significant numbers of spirochetes in blood and skin, and
that this occurs despite the known presence of circulating
anti-treponemal antibodies and strong cellular immune
responses associated with this stage of the disease.
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reviewed by ethics committee from each of the participating ESEs.
The Institutional review board at the Centers for Disease Control
and Prevention (CDC) approved the molecular analysis of Tp
DNA in blood samples and skin biopsies obtained from secondary
syphilis patients and controls.
Figure 1. Study site and syphilis network. The city of Cali is located in south-western Colombia (see inset). Cali is divided into 22 (numbered in
the figure) distinct geographic districts called ‘‘comunas’’. These are clustered within 5 administrative regions called Empresas Socials del Estado
‘‘ESEs’’: Ladera (yellow), North (blue), Center (pink), South-East (purple) and East (green). Public health hospitals are strategically distributed within the
‘‘ESEs’’. The syphilis patient recruitment network was comprised of 13 hospitals and health centers located throughout the city.
doi:10.1371/journal.pntd.0000690.g001
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The diagnosis of secondary syphilis was based on a compatible
medical history, the appearance of characteristic skin or mucosal
lesions (see below), a reactive RPR of $1:4 dilutions, and a
positive confirmatory treponemal test (Fluorescent Treponemal
Antibody Absorption, FTA-ABS). All subjects had a complete
physical examination performed by one of two trained
dermatologists (AC or RT) who are well versed in the
identification of venereal syphilis. Individual case histories,
serologic data, and photographs of dermal and cutaneous lesions
were then reviewed by at least one of two infectious disease
experts (JR or JS). Serologic tests for syphilis and HIV were
conducted for all participants at a centralized reference
laboratory in Cali. Study subjects were not eligible for
participation if they were ,18 years old, if they were known
to be HIV+ or if they had used antibiotics within 4 weeks prior
to study entry. Pregnant women were also excluded from
participation. Socio-demographic characteristics and relevant
clinical and epidemiological information were obtained by
means of a standardized questionnaire. Study dermatologists
obtained skin biopsies from 11 patients who had representative
syphilis dermal lesions. Whole blood and skin biopsies were also
collected from a subset of patients for real time polymerase chain
reaction (PCR) Tp DNA quantitation (see below). All patients
were treated with 2.4 million units of intramuscular benzathine
penicillin in accordance with Colombian public health guide-
lines, which are in accord with available CDC treatment
guidelines [22]. Patients were asked to return within 45–60 days
for a follow-up clinical examination and repeat RPR titers.
When possible, partner notification and treatment were done by
health care providers from the city of Cali’s health department.
Diagnosis and treatment of additional STDs was done through
the patient’s primary health care provider.
Clinical Laboratory and Histologic Studies
All patients had non treponemal (RPR), and treponemal
(FTA-ABS) tests performed at a reference laboratory in
Colombia. An ECLIA (Electro-chemiluminescence Immunoas-
say) HIV serum antibody test, a complete blood count (CBC)
with manual differential, and quantitation of the erythrocyte
sedimentation rate (ESR) were also done. All women underwent
a serum pregnancy test (none were positive). The three positive
HIV ECLIAs identified in study patients were subsequently
confirmed by Western-blot analysis. HIV-positive patients were
referred to a public health care sector HIV clinic for additional
testing and treatment. Dark field microscopy was not required in
this study. Punch biopsies from affected dermal sites were
obtained by the study dermatologist from 11 patients deemed to
have distinctive clinical manifestations classically associated with
SS. Available tissues from these patients were stained with both
hematoxilin-eosin (H&E) and Warthin-Starry silver stain (one
(9%) revealed spirochetes by silver stain). Individual biopsy
samples were then systematically analyzed by trained patholo-
gists in Colombia and subsequently corroborated by a pathol-
ogist in the United States.
Molecular Studies
The clinical sensitivity of the polA real-time PCR was
determined by testing blood spiked with either purified Tp
DNA or Tp organisms. Fifty milliliters of peripheral blood was
collected in EDTA tubes from a single donor. The blood sample
was maintained at room temperature prior to performing spiking
experiments. Tp was grown in the testis of New Zealand white
rabbits and harvested as previously described [23]. The
cultivation of T. pallidum in rabbits was approved by the CDC
animal care committee. Treponemes were diluted to a concen-
tration of 1.5610
7/ml using prewarmed TpCM (Tp cultivation
medium). A ten-fold serial dilution of the suspension was
performed using prewarmed TpCM and a 200ml aliquot of each
ten-fold dilution was added in duplicate to 1.8 ml of blood. One
set of tubes was kept at room temperature for 1 hr while the
second set was placed in a refrigerator for 26 hrs. DNA was
extracted from a 200ml aliquot of the 10
21 dilution of Tp
organisms in TpCM using the QIAamp DNA Mini Kit (Qiagen,
Valencia, CA). The purified DNA was serially diluted ten-fold in
sterile PBS and a 200ml aliquot of each ten-fold dilution was
added in duplicate to 1.8 ml of blood. Tubes were left at room
temperature for 1 hr or stored at 4uC as for blood spiked with Tp
organisms. DNA extraction from all spiked blood samples was
achieved using the QIAamp DNA Midi kit (Qiagen) and the
purified DNA was eluted in 500ml Buffer AE. A 10ml sample was
tested in duplicate using a real-time PCR that targets the DNA
polymerase I gene of Tp (polA).
Five to ten milliliters of whole blood were collected in tubes
containing EDTA (1.8mg EDTA per milliliter of blood) from 26
SS patients enrolled during the last three years of the study. The
first 15 WB samples collected were stored frozen for several days
and subsequently shipped on dry ice overnight to UCHC. DNA
was subsequently extracted from 0.4 ml of whole blood using the
QIAamp DNA Blood Mini Kit (Qiagen) following procedures
recommended by the manufacturer. For the last eleven patients
enrolled into the study DNA was extracted from whole blood
samples on site by CIDEIM personnel, and subsequently shipped
on dry ice to UCHC. A 4 mm-punch skin biopsy of SS lesions was
also obtained from the same group of patients and controls, snap-
frozen and stored in liquid nitrogen in preparation for overnight
transportation on dry ice to UCHC. Skin from three healthy
controls was also obtained at CIDEIM and handled in the same
fashion. Upon arrival at UCHC, DNA was extracted from all skin
samples using the Qiagen DNAeasy Blood and Tissue kit (Qiagen).
DNA samples from both the skin and WB were eventually shipped
on dry ice to the Laboratory Reference and Research Branch,
Division of STD Prevention, at the CDC in Atlanta, Georgia for
diagnostic PCR testing. Samples were tested using a real-time
PCR targeting the Tp polA gene (Gene Bank Accession
No. U57757) as described below.
PCR amplification was performed using forward primer TP-1
(59CAGGATCCGGCATATGTCC39), reverse primer TP-2
(59AAGTGTGAGCGTCTCATCATTCC39), and probe TP-3
(59CTGTCATGCACCA GCTTCGACGTCTT39) as previously
published [24] with some exceptions. The probe was labeled with
Cyanine (Cy5) at the 59 end and black-hole quencher 3 (BHQ3) at
the 39 end. PCR was performed in 50ml reaction volumes
containing the following: 4ml of deoxynucleoside triphosphate
mix (2.5mM of dATP, dCTP, dGTP, and 5.0mM of dUTP), 6ml
of MgCl2 (25 mM), 0.2mM of each primer, 0.6U uracil N-
glycosylase, 5U of AmpliTaq Gold polymerase, 5mlo f1 0 6PCR
buffer (All Applied Biosystems, Foster City, CA), 0.2mM of probe,
and 12ml of template DNA. Thermocycling was performed in a
Rotor-Gene 6000 instrument (Qiagen) as follows: 50uC for 2 min
and 95uC for 10 min and 45 cycles of 95uC for 20 sec and 60uC
for 1 min. Each PCR run included positive and negative (no
template) control reactions. The Tp copy numbers for each WB
specimen were extrapolated from the standard curve generated
using ten-fold serial dilutions of purified Tp DNA. A human
ribonuclease (RNase) P gene PCR assay was used, as previously
described [25], to test for PCR inhibition in blood samples that
were negative by the polA real-time PCR assay.
Secondary Syphilis in Colombia
www.plosntds.org 4 May 2010 | Volume 4 | Issue 5 | e690T. pallidum Molecular Typing
Strain typing was attempted for all WB and skin samples
obtained from SS patients, which were Tp-positive by diagnostic
PCR. PCR amplification and sizing of the 60-bp tandem repeats
within the arp (acidic repeat protein) gene and PCR-restriction
length polymorphism (RFLP) analysis of tpr (T. pallidum repeat) E,
G, and J genes was done as previously described by Pillay et al.
[26,27], with two modifications. First, the tandem repeat region
within the arp gene was amplified with a new primer pair, N1
(59ATCTTTGCCGTCCCGTGTGC39) and N2 (59CCGAGTG-
GGATGGCTGCTTC39) using the existing PCR conditions for
the arp assay. Second, all PCR amplicons were analyzed on an
Agilent 2100 Bioanalyzer (Agilent Technologies, San Diego,
California).
Results
Socio-Demographic Features of Secondary Syphilis
Patients
A total of 57 patients (age 18–64 years, median 31 years) met
the case definition for SS and were recruited by a network of
primary health care providers located throughout Cali (Figure 1).
All enrolled SS patients resided in comunas of the city of low or
very–low socio-economic conditions. Most participants were either
unschooled (10.5%) or had only partially completed elementary
school education (59.6%). Because we did not directly target more
affluent communities in Cali, we are unable to decisively conclude
that SS principally affects underprivileged groups. Consistent with
prior SS case series [14], the majority of SS patients enrolled were
women (64.9%). Most participants were either Afro-Colombian
(38.6%) or of mixed race (mestizo) (56.1%). Given that 25.3% of
the general population in this region of the country is of Afro-
Colombian background [28], it is evident that in this study blacks
were proportionately over-represented. The majority of subjects
self-reported a high-risk sexual behavior history (62.5%), including
having multiple sexual partners, rarely using condoms, and/or
having contact with commercial sex workers. Almost a quarter
(24.6%) gave a history of illicit drug use and 59.6% stated that they
consumed alcohol routinely. One male patient admitted to having
had unprotected sex with other men as the principal risk factor for
acquiring syphilis. 5.3% of the subjects enrolled in our study were
newly diagnosed with HIV. A diagnosis of HIV co-infection is
consistent with available epidemiologic and biologic evidence
demonstrating that infection with Tp increases the likelihood of
both transmitting and acquiring HIV [12,29–31].
Secondary Syphilis Patients Clinical and Laboratory
Findings
The mean duration of signs and symptoms at the time of
presentation was 78.6 days (range 5–240), with a median duration
of 30 days. A history of undocumented fever was not uncommon
(15.8%); however, none of the patients enrolled was febrile at the
time of the initial physical examination. Many patients reported
mild to moderate flu-like symptoms (42.1%), and all had dermal
and mucosal findings which were in accord with previously
described dermatologic manifestations of SS [32,33] (Table 1).
The typical palmar and plantar exanthem of SS [13,15,19,32–34]
was the most common dermal manifestation (59.6%). As seen in
figure 2, palmar and plantar lesions were often surrounded by
hyperkeratosis and thin white rings or collar of scales; the latter has
been classically known as Biett’s collarette [34]. In agreement with
Chapel’s [32] and Mindel’s classic descriptions of SS [32,33], most
subjects also had faint macular and papular eruptions, which were
diffusely disseminated over the trunk and upper and lower
extremities (Figure 3A–B). In many cases, the dermal lesions were
hyperpigmented (Figure 3G), a finding which, not surprisingly,
was more evident in darker skinned individuals. Condyloma lata,
which are known to be highly infectious [1,13,14], were present in
15% of patients (Figure 3C and D). In one subject, several very
large frambesiform, pustular lesions, a rare manifestation of the
disease [34], were plainly evident over the naso-labial folds and
lower jaw (not shown). Three patients had the characteristic
patchy ‘‘moth-eaten-like’’ alopecia (Figure 3E), which resolved
after penicillin treatment. Mucosal patches in genital areas and/or
the oral mucosa, also commonly seen in this stage of the disease,
were observed in 14% of patients (Figure 3F). Although early
dissemination to the central nervous system (CNS) is known to
occur in up to 40% of SS patients [1,35,36], none of the
participants had overt clinical manifestations associated with
meningitis or encephalitis (i.e. meningismus, cranial nerve
disorders, visual changes or intense headache). The majority of
patients (94.7%) had RPR titers $than 1:16 and over a third
(36.8%) had titers $1:128. RPR titers at follow-up decreased at
least four-fold in all patients followed at 40–60 days. Hematologic
anomalies, indicative of the systemic inflammatory nature of this
stage of the disease, were the norm in most patients studied.
Indeed, more than half of all patients had an elevated erythrocyte
sedimentation rate (ESR) (63.2%), 30% were anemic and several
were lymphopenic (43.9%). It is possible, although unlikely, that
the hematologic changes described herein are a reflection of other
Table 1. Signs and symptoms associated with secondary
syphilis.
Symptom and Signs No. (%) of Patients
This Study Chapel * Mindel et al. **
Headache 8/57 (14) 9/105 (9) 17/854 (2)
Fever 9/57 (16) 5/105 (5) 45/822 (6)
Malaise 14/57 (25) No data 106/831 (13)
Weight loss 3/57 (5) 2/105 (2) No data
Musculoskeletal aches 3/57 (5) 6/105 (6) No data
Pruritus 8/57 (14) 44/105 (42) No data
Adenopathy 14/57 (25) 90/105 (86) 490/780 (63)
Type of skin lesions
Diffuse exanthem 31/57 (54) 7/105 (7) 775/830 (93)
Macular 9/57 (16) 10/105 (10) 301/763 (40)
Maculopapular 9/57 (16) 73/105 (70) 301/763 (40)
Papular 7/57 (12) 13/105 (12) 78/763 (10)
Papulo-pustular 1/57 (2) 2/105 (2) No data
Psoriasiform 1/57 (2) 1/105 (1) No data
Condylomata lata 7/57 (12) 9/105 (9) 37/821 (5)
Hair loss 3/57 (5) 3/105 (3) 32/824 (4)
Site
Palms 30/57 (53) 54/105 (55) 346/775 (45)
Soles 32/57 (56) 62/105 (59) 337/773 (44)
Trunk 15/57 (26) 61/105 (58) 571/788 (73)
Genitals 13/57 (23) 58/105 (55) 265/759 (35)
Mucosa 15/57 (26) 22/105 (21) No data
*[32].
**[33].
doi:10.1371/journal.pntd.0000690.t001
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Histological Findings
Table 2 summarizes the various histopathologic anomalies that
were seen in lesional punch biopsies obtained from 11 of the 57 SS
patients enrolled. In concert with prior histologic descriptions of
SS [14,34,35,37–40], skin biopsies revealed superficial and deep
dermal cellular infiltrates of varying intensity, often in a
perivascular distribution and primarily comprised of lymphocytes
and plasma cells. Several other histologic patterns involving the
epidermis were also seen. These included areas of focal spongiosis,
basal vacuolar changes, parakeratosis, and epidermal acanthosis.
Figure 4 depicts representative histopathologic abnormalities from
four SS patients. In concert with the known low sensitivity of the
Warthin-Starry stains to detect Tp in tissues [39,40], spirochetes
were only seen in one (9%) of the 11 biopsies studied.
Detection of Tp DNA (polA) in Whole Blood (WB) of
Secondary Syphilis Patients by Real-Time Quantitative
PCR (qPCR)
We previously determined that WB was the best sample to
detect spirochetes in blood obtained from infected rabbits [41]. In
unpublished observations we confirmed that using spiked human
blood, WB was better than serum, plasma or peripheral blood
mononuclear cells (PBMCs) for detecting spirochetes. In this study,
we therefore elected to use WB samples to quantitate the level of
spirochetemia in untreated SS patients. Using a real-time qPCR
assay targeting the polA gene, we first established the sensitivity of
the assay to be between 15 and 150 spirochetes/ml, irrespective of
Figure 2. Palmar and plantar rash of secondary syphilis. Typical palmar and plantar rash of secondary syphilis is shown in the representative
figures. Similar lesions were evident in 59.6% of all secondary syphilis subjects enrolled. These lesions consist of smooth or scaly plaques and papules,
which can become hyperpigmented in dark-skinned individuals as shown in the figure.
doi:10.1371/journal.pntd.0000690.g002
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diversity of dermatologic lesions and which can be confounded with other cutaneous diseases. (A and B) Diffuse erythematous papular exanthem is
shown over abdomen in A and lower extremity in B. (C and D) Multiple moist, hypopigmented, flattened plaques consistent with condyloma lata are
shown on external genital areas (male and female respectively in C and D). (E) Inflammatory responses can affect hair follicles leading to ‘‘moth-eaten
alopecia’’ as depicted in the figure. (F) Oral mucosal patches, as shown in the figure can be present during secondary syphilis. (G) Pigmentary plaques
are shown over the buttocks of a dark-skinned secondary syphilis patient. (H) Psoriasiform syphilitic lesions, as shown in the representative
micrograph, could easily be misdiagnosed as psoriasis.
doi:10.1371/journal.pntd.0000690.g003
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used to spike the blood sample (Table S1). The polA PCR
detection limit in blood samples that were immediately refriger-
ated upon spiking and kept at 4uC for a total of 26 hrs prior to
DNA extraction, were one log higher than samples kept at room
temperature for 1 hr and then processed. We then used this highly
sensitive PCR method to amplify Tp DNA in 46% (11/26) of the
WB samples obtained from SS patients (Table 3). The polA copy
numbers in these patients ranged from 194.92 to 1954.2 copies/ml
of WB, which is well above the cutoff for the assay. PCR inhibition
was not observed in any of the DNA samples that tested negative
for the Tp polA target. It is important to note that the ability to
detect Tp DNA in SS patients’ samples greatly improved when
WB DNA was extracted within a few hours of procurement of the
sample. Indeed, 63% (7/11) of the samples handled in this fashion
had detectable Tp DNA, whereas only 5/15 (30%) WB samples
were positive when WB was collected, frozen and shipped to
UCHC for subsequent DNA extraction at the CDC. These
findings highlight the importance of timely specimen processing
and handling, and show how subtle differences in technique can
greatly alter the ability to amplify Tp DNA.
Tp Was Readily Detected in Skin Samples of SS Patients
Tp DNA was also detected by qualitative real-time PCR in 8/12
(66%) skin biopsies studied (Table 4). Three of the four skin
biopsies that did not have detectable Tp DNA by RT-PCR were
obtained from hyperkeratotic plantar plaques. Five of the 8
patients had Tp DNA present in both the blood and the skin, one
patient with spirochetemia had a negative PCR in the skin; and
two patients with detectable DNA in punch biopsy material had
negative PCR results in WB.
Tp Strain Typing
None of the WB samples analyzed had sufficient quantity of Tp
DNA to satisfactorily perform molecular strain typing. On the
other hand, six of the eight positive skin samples were amenable
for typing. By combining the 60-bp arp repeat sizes and the tpr E,
G, and J RFLP patterns, we identified four different strain types;
two each were 14d and 16d, and one each was 13d and 22a,
respectively. The remaining strain was partially typeable by tpr
RFLP analysis (pattern a). Although it is not possible to generalize
our results due to the small sample size, our data suggests high
strain diversity, which reflects the pattern seen in South Africa
[27], where syphilis is known to be highly endemic.
Discussion
The WHO estimates that up to a quarter of all yearly cases of
infectious syphilis occur in Latin America and the Caribbean [3].
Because syphilis is not rigorously notified, and often not
recognized by health care providers in the region, country-specific
disease prevalence and incidence rates most likely underestimate
the true magnitude of the problem. Existing published studies do
provide evidence that venereal syphilis is not only highly endemic
but also a very important sexually transmitted disease in tropical
regions of the Americas [42–57]. For instance, syphilis has been
shown to be a leading cause of genital ulcerative disease in both
Peru and the Dominican Republic [56], second only to genital
herpes. Likewise, in another study from Peru, the prevalence of
venereal syphilis was estimated to be 10.5% amongst MSM and
2.0% in socially marginalized men and women [42]. In a Brazilian
study, high syphilis prevalence rates were the norm in prisoners,
commercial sex workers, and MSM [47]. High syphilis prevalence
rates have also been documented for MSM (5% and 13%) and
female sex workers (6.8% and 15.3%) in Honduras and
Guatemala respectively (Source: PAHO web site http://new.
paho.org accessed July, 2009). In one of the few available studies
describing the epidemiology of venereal syphilis in Colombia, 10%
of female sex workers in Bogota had serologic and clinical evidence
of the disease [51]. Although the current study was not designed to
be a comprehensive epidemiologic or microbiologic investigation
of syphilis in Cali, our combined observations do provide further
evidence that venereal syphilis is highly endemic in this region of
Colombia. This assertion was further substantiated by the very
high syphilis seroprevalence rates documented in 15–24 year old
sexually active men and women from poor Cali districts [7].
Our findings also make evident that early syphilis patients in
Cali may go undiagnosed and untreated for several weeks, in some
cases for several months. This is not at all surprising given that the
clinical manifestations of SS are often subtle and can be easily
overlooked and/or dismissed by primary care providers and
patients alike. A principal objective of the current case series is
thus, to review for health care providers, particularly those who
practice medicine in tropical regions like Colombia, the typical
clinical manifestations associated with SS. Although a large
proportion of patients presented with the classic palmo-plantar
exanthem of SS [19,32,34], some had faint hypo or hyper-
pigmented macules and papules that could have easily been
dismissed for other dermatologic conditions. Indeed, the rash of SS
may be frequently confused for other skin disorders including
pityriasis rosea, psoriasis, seborrheic dermatitis and dermato-
mycosis, amongst others [13]. Given the relative high prevalence
of venereal syphilis in this population, it is not unreasonable to
Table 2. Histologic abnormalities observed in secondary
syphilis skin lesions (n=11).
Characteristic Features of Inflammatory Infiltrate N (%)
Degree of inflammation
Sparse 5 (45)
Moderate 2 (18)
Dense 4 (36)
Location
Superficial 10 (91)
Deep 2 (18)
Perivascular 9 (82)
Diffuse 2 (18)
Periadnexal 4 (36)
Predominant inflammatory cells
Lymphocytes ++++
Plasmocytes +++
Macrophages ++
Neutrophils +
Eosinophils +
Epidermal changes
Exocytosis 11 (100)
Necrotic keratinocytes 4 (36)
Spongiosis 11 (100)
Psoriasiform alterations 5 (45)
Acanthosis 8 (73)
doi:10.1371/journal.pntd.0000690.t002
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syphilis patients skin lesions. Corresponding clinical appearance of the lesions are also shown. (A) Markedly inflamed hair follicle (‘‘folliculitis’’) with
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active individuals who present with any form of unexplained skin
and mucous membrane pathology, and perhaps even in
individuals with otherwise unexplained constitutional flu-like
symptoms.
Several other investigators have previously used molecular
methods to detect Tp DNA in WB and tissues from untreated early
syphilis patients [58–65]. Our study is the first to measure
spirochetal loads by real time qPCR in the blood of untreated SS
patients. The ability to detect spirochetal DNA in these samples
has been quite variable and highly dependent on various factors
including; the type of sample collected, the stage of the disease
(primary vs. secondary vs. latent), and the gene target used.
Nevertheless, it is readily apparent that a significant proportion of
early syphilis patients, regardless of the stage of the disease, have
circulating spirochetal DNA. In the current study, the detection
limit in blood samples that were spiked with either DNA or whole
Tp organisms and kept at 4uC for 26 hrs was 15 polA copies/ml
blood compared to 150 polA copies/ml in the same dilutions stored
at room temperature for 1 hr. While frozen blood samples, stored
over several days, may not be conducive to diagnostic PCR testing,
our spiking experiments do indicate that blood samples can be
stored up to 26 hours at 4uC without significantly affecting the
capacity to detect Tp DNA. This may prove to be particularly
useful in settings where blood samples cannot be processed on the
day of collection. No PCR inhibition was observed with the use of
2ml blood for spiking experiments, despite the inherent high
concentration of human DNA in these samples. It is possible that
several other SS patients enrolled, if not all, were spirochetemic
but not detected by qPCR. This may have been due to some
extension of inflammatory cell infiltrate into parafollicular blood vessel and connective tissue. Corresponding ‘‘moth-eaten’’ alopecia is shown in the
adjacent micrograph. (B) Dark-skinned patient (pigmented basal keratinocytes); further darkening of a patch of skin in the form of a macule, as shown
herein, is caused by deposition of dermal melanophages (‘‘pigment incontinence’’) (C) Skin biopsy obtained near the sole reveals a thick stratum
corneum layer, epidermal reactive psoriasiform hyperplasia associated with chronic inflammation of the dermal papilla, and a superficial perivascular
lymphoplasmocytic infiltrate. (D) Edge of an ulcer located in the lower extremity reveals fibrinoid exudate on the ulcer bed, surrounded by
granulation tissue and reactive hyperplasia of the epidermis.
doi:10.1371/journal.pntd.0000690.g004
Table 3. Quantitation of T. pallidum DNA in whole blood (WB) samples by real-time PCR (n=26).
Subject # Sample polA diagnostic PCR Ct value Copies/mL blood ** RPR titer
20 WB 22 2 1:4
27 WB + 35.65 482.0 1:128
28 WB 22 2 1:64
29 WB 22 2 1:128
34 WB 22 2 1:16
39 WB + 36.24 322.4 1:16
40 WB + 35.96 392.3 1:32
42 WB + 34.84 847.2 1:256
43 WB + 36.32 304.9 1:64
44 WB 22 2 1:16
50 WB 22 2 1:64
56 WB 22 2 1:16
57 WB 22 2 1:128
58 WB 22 2 1:256
59 WB 22 2 1:16
*64 WB + 35.67 479.8 1:256
*71 WB + 36.15 342.4 .1:256
*72 WB + 34.82 857.2 1:64
*73 WB + 34.62 989.6 1:128
*74 WB + 36.97 194.9 1:128
*76 WB + 33.63 1954.2 1:64
*77 WB 22 2 1:128
*80 WB 22 2 1:256
*84 WB + 35.1 612.3 1:128
*87 WB 22 2 1:256
*96 WB 22 2 1:64
% positive: 46%
*DNA was extracted immediately after obtaining the samples.
**Reliable detection limit of the assay was between 15 and 150 copies/ml.
doi:10.1371/journal.pntd.0000690.t003
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the assay or alternatively, treponemal DNA might have been
degraded as a result of not being extracted within 24 hours of
blood collection. For future studies the ability to detect low copy
numbers may be enhanced by extracting DNA on site and using a
larger volume of blood (2ml vs. 400ml).
In this study we also performed Tp strain type analysis in DNA
material obtained from the skin of several SS patients. Using the
method described by Pillay [27,66,67] we provide evidence that in
the city of Cali there is considerable heterogeneity in circulating
Tp strains. Subtype 14d, which is known to have a worldwide
distribution [27,62,68], was present in the skin of two SS patients.
Subtypes 13d and 16d, which were previously identified in syphilis
patients in several cities in South Africa [27], were also present in
skin samples in Cali. Strain type diversity in Cali, provides
additional evidence that venereal syphilis is highly endemic in this
population. In a much larger molecular epidemiology study
conducted in several South African cities [27], greater geographic
Tp strain diversity was found to correlate statistically with higher
syphilis prevalence rates. It is our contention that an improved
understanding of the heterogeneity of syphilis subtypes, not only
helps to identify the introduction of new strains into an endemic
population but also helps to evaluate if public health strategies
have been successful at eradicated indigenous strains.
As already alluded to above, the molecular methods used herein
provide evidence that significant numbers of spirochetes are not
only present in the skin, but are also capable of spreading in
significant numbers through the blood stream of untreated SS
patients. Paradoxically, SS patients exhibit robust cellular and
humoral adaptive immune responses [10,17,69,70]. A careful
analysis of Tp’s unique ultrastructural features provides several
explanations for this paradox. Unlike the outer membrane of
gram-negative bacteria, that of Tp lacks the potent proinflamma-
tory glycolipid lipopolysaccharide (LPS) [71,72]. In addition,
freeze-fracture microscopy studies have shown that the spirochete
is largely devoid of integral outer-membrane proteins [73,74].
Although Tp does contain an abundance of highly antigenic
hydrophilic polypeptides, these molecules are tethered by
covalently bound N-terminal lipids to the periplasmic leaflet of
the cytoplasmic membrane [74,75]. This unusual topology is
thought to contribute to the ability of intact spirochetes to avoid
recognition by innate immune cell (i.e. macrophages) pattern
recognition receptors (PRR); thus delaying or impeding their
activation at the sites of initial inoculation or in skin or organs to
where spirochetes have disseminated. Inefficient antibody binding
to the small number of potential antigenic targets present on the
spirochete’s outer membrane could also allow the spirochete to
shun rapid and efficient binding by opsonizing anti-treponemal
antibodies and thus avoid phagocytosis. One can envision a model
were the paucity of outer membrane antigenic targets, perhaps in
combination with the very slow rate of bacterial replication,
facilitates intermittent low level spread of the spirochete from
affected skin and mucous lesions into the blood stream of
untreated SS patients. Lastly, sequence variation of the Tp repeat
(Tpr) family of polymorphic multi-copy repeat proteins has been
postulated as an additional mechanism of immune evasion and
persistent infection by the spirochete [17,76–78]. Of the several
proteins with predicted outer membrane location, TprK has
received the most attention. Although controversy remains as to
the actual location of TprK [79], sequence diversity of tprK in
samples obtained from several syphilis patients [76] has bolstered
the idea that this molecule could play an important role in
immune evasion. Several other candidate outer membrane
proteins, including Tp92 [80], are currently being studied to
determine if they meet the structural features of other known
bacterial outer membrane proteins, if they bind syphilitic opsonic
antibodies, and if they too can undergo antigenic variation.
We conclude that high syphilis prevalence rates in the region
should prompt health care workers in countries like Colombia to
maintain a high index of suspicion for the common and
uncommon manifestations of early syphilis. In concert with the
clinical findings highlighted herein, a diagnosis of SS must be
considered as part of the differential diagnosis in any subject
who presents with chronic skin and/or mucosal lesions. Public
health care authorities must redouble their efforts to enhance
early detection of venereal syphilis, to institute timely treatment
of the disease and to improve follow-up of patients diagnosed
with the disease. Lastly, research efforts designed to better
understand the immunopathogenesis of the disease, in particular
how the bacterium is able to elude host immunologic defenses
and spread from sites of bacterial replication, as demonstrated
herein, will greatly contribute to more effective and novel
prevention strategies, including the development of an effective
vaccine.
Table 4. Patients and strain type analysis using DNA obtained from skin lesions.
Subject WB polA PCR Skin polA PCR Strain type (Skin) Punch biopsy site Description of the lesion
71 ++ 22a Epigastrium Erythematous Plaque
72 ++ 14d Posterio lumbar Erythematous Plaque
73 ++ 13d Right iliac crest Erythematous Plaque
74 + 22 Right sole Plaque
75 NA 22 Left sole Plaque
76 ++ 16d Posterior neck Lichenoid plaque
77 2 + 16d Right ankle (external maleolus) Psoriasiform Plaque
80 22 2 Right sole Plaque
84 ++ 14d Posterior neck Lichenoid plaque
87 22 2 Right leg (distal tibia) Plaque
96 2 + 2 Posterior lumbar Hyperpigmented plaque
99 NA + ?a Left anterior thigh Erythematous Plaque
doi:10.1371/journal.pntd.0000690.t004
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Table S1 Sensitivity of polA real-time PCR.
Found at: doi:10.1371/journal.pntd.0000690.s001 (0.03 MB
DOC)
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